SEC
NPSP

Seven Eight Capital’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Seven Eight Capital’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,250
Closed -$111K – 766
2014
Q3 		$111K Buy
+4,250
New +$122K 0.08% 307

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Seven Eight Capital's NPSP Position: Q4 2014 in Review

Seven Eight Capital sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2014, closing a stake of 4,250 shares — an estimated $111K sold.

Seven Eight Capital first reported a position in NPSP in Q3 2014 and held it in 1 quarter. The position peaked at $111K in Q3 2014. 213 funds tracked by Wall St. Rank hold NPSP as of Q4 2014.

  • Seven Eight Capital reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Seven Eight Capital sold 4,250 NPS PHARMACEUTICALS INC shares in Q4 2014, an estimated $111K.
  • Seven Eight Capital first reported a position in NPS PHARMACEUTICALS INC in Q3 2014 and held it in 1 quarter.
  • Seven Eight Capital's NPS PHARMACEUTICALS INC position peaked at $111K in Q3 2014.
  • 213 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2014.

Based on Seven Eight Capital's 13F filing for Q4 2014, filed 13 Feb 2015.